Author Correction: Glucose homeostasis is regulated by pancreatic β-cell cilia via endosomal EphA-processing

Author Correction: Glucose homeostasis is regulated by pancreatic β-cell cilia via endosomal EphA-processing

Bibliographic Details
Main Authors:	Francesco Volta, M. Julia Scerbo, Anett Seelig, Robert Wagner, Nils O’Brien, Felicia Gerst, Andreas Fritsche, Hans-Ulrich Häring, Anja Zeigerer, Susanne Ullrich, Jantje M. Gerdes
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-08-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-021-24865-4

Similar Items

Glucose homeostasis is regulated by pancreatic β-cell cilia via endosomal EphA-processing
by: Francesco Volta, et al.
Published: (2019-12-01)

Islet vascularization is regulated by primary endothelial cilia via VEGF-A-dependent signaling
by: Yan Xiong, et al.
Published: (2020-11-01)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
by: Malgorzata Gajdzis, et al.
Published: (2020-09-01)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
by: Hatano Manabu, et al.
Published: (2004-11-01)

Targeting EphA2 in cancer
by: Ta Xiao, et al.
Published: (2020-08-01)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia.
by: Sara Charmsaz, et al.
Published: (2015-01-01)

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
by: Zhongzhen Yi, et al.
Published: (2018-06-01)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
by: Jae Min Shin, et al.
Published: (2023-02-01)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
by: Maki Murakoshi, et al.
Published: (2022-12-01)

EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
by: Mario Cioce, et al.
Published: (2021-02-01)

A Novel Occulta-Type Spina Bifida Mediated by Murine Double Heterozygotes EphA2 and EphA4 Receptor Tyrosine Kinases
by: Nor Linda Abdullah, et al.
Published: (2017-12-01)

Differential roles for EphA and EphB signaling in segregation and patterning of central vestibulocochlear nerve projections.
by: Michelle R Allen-Sharpley, et al.
Published: (2013-01-01)

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
by: Shuang Cui, et al.
Published: (2021-03-01)

Effects of Eph/ephrin signalling and human Alzheimer's disease-associated EphA1 on Drosophila behaviour and neurophysiology
by: Edgar Buhl, et al.
Published: (2022-08-01)

Structures of the EphA2 receptor at the membrane: Role of lipid interactions
by: Chavent, M, et al.
Published: (2017)

EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer
by: Robiya Joseph, et al.
Published: (2024-01-01)

Role of EphA4 in Mediating Motor Neuron Death in MND
by: Jing Zhao, et al.
Published: (2021-08-01)

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
by: Carolin Offenhäuser, et al.
Published: (2018-12-01)

Theoretical Model of EphA2-Ephrin A1 Inhibition
by: Wiktoria Jedwabny, et al.
Published: (2018-07-01)

Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors
by: Nikki Cheng, et al.
Published: (2003-09-01)

EphA7 isoforms differentially regulate cortical dendrite development.
by: Carrie E Leonard, et al.
Published: (2020-01-01)

Evidence that the EphA2 receptor exacerbates ischemic brain injury.
by: John Thundyil, et al.
Published: (2013-01-01)

EphA4 defines a class of excitatory locomotor-related interneurons.
by: Butt, S, et al.
Published: (2005)

Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury
by: Areumnuri Kim, et al.
Published: (2020-11-01)

Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates
by: Parima Udompholkul, et al.
Published: (2021-06-01)

Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
by: Santosh K. Dasari, et al.
Published: (2023-02-01)

EphA7 promotes myogenic differentiation via cell-cell contact
by: Laura L Arnold, et al.
Published: (2020-04-01)

Pinpointed Stimulation of EphA2 Receptors via DNA-Templated Oligovalence
by: Christin Möser, et al.
Published: (2018-11-01)

Upregulation of EphA Receptor Expression in the Injured Adult Rat Spinal Cord
by: Christopher A. Willson, et al.
Published: (2002-04-01)

Role of EphA2 in host defense against oro-pharyngeal candidiasis
by: Ingar Olsen
Published: (2020-01-01)

EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria.
by: Thayer K Darling, et al.
Published: (2020-01-01)

Anti-EphA2 Antibodies Decrease EphA2 Protein Levels in Murine CT26 Colorectal and Human MDA-231 Breast Tumors But Do Not Inhibit Tumor Growth
by: David Kiewlich, et al.
Published: (2006-01-01)

Structurally encoded intraclass differences in EphA clusters drive distinct cell responses.
by: Seiradake, E, et al.
Published: (2013)

Interactions of the EphA2 kinase domain with PIPs in membranes: implications for receptor function
by: Chavent, M, et al.
Published: (2018)

Structurally encoded intraclass differences in EphA clusters drive distinct cell responses
by: Seiradake, E, et al.
Published: (2013)

Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
by: Ahmed F. Salem, et al.
Published: (2020-05-01)

EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells.
by: Xiao-Dong Dong, et al.
Published: (2023-05-01)

Overexpression of hepatocyte EphA2 enhances liver-stage infection by Plasmodium vivax
by: Sittinont Chainarin, et al.
Published: (2022-12-01)

Modeling development in retinal afferents: retinotopy, segregation, and ephrinA/EphA mutants.
by: Keith B Godfrey, et al.
Published: (2014-01-01)

The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
by: Wenfan Zhang, et al.
Published: (2022-06-01)